In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
OCRA Joins Global Leaders to Propel Ovarian Cancer Research Forward at HHMT Conference
Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at … Continued
Closing Video of BlackDoctor.org Series with OCRA Outlines Support, Resources
In the final installment of BlackDoctor.org’s six-part video ovarian cancer video series in partnership with Ovarian Cancer Research Alliance (OCRA), the discussion turns to the availability of support and resources … Continued
Make a Difference with OCRA on GivingTuesday
“Hope is stronger than fear. Knowledge is power.” —Janice, Mentor with OCRA’s Woman to Woman Peer Mentor Program This GivingTuesday, YOU Can Help Shape the Future of Ovarian and Gynecologic … Continued